SCHEMBL355111

SCHEMBL355111

CCN(C)Cc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.61
ALDH1A1 P00352 3/20 0.61
CHRNB2 P17787 1/20 0.61
CHRNA4 P43681 1/20 0.61
CARM1 Q86X55 1/20 0.59
PRMT6 Q96LA8 1/20 0.59
PRMT8 Q9NR22 1/20 0.59
LMNA P02545 3/20 0.57
CYP3A4 P08684 2/20 0.57
USP2 O75604 1/20 0.57
MAOA P21397 1/20 0.57
MAOB P27338 1/20 0.57
PYCR1 P32322 1/20 0.57
AOC3 Q16853 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.55
BLM P54132 1/20 0.55
SIGMAR1 Q99720 1/20 0.53
KDM4E B2RXH2 1/20 0.53
CNR2 P34972 1/20 0.50
CYP1A2 P05177 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1331237 0.98 ALDH1A1 (0.59) TSHRALDH1A1CHRNB2CHRNA4CARM1
Bromide SCHEMBL1331743 0.98 CHRNB2 (0.59) TSHRALDH1A1CHRNB2CHRNA4CARM1
Ethane SCHEMBL28875373 0.98 CHRNB2 (0.59) TSHRALDH1A1CHRNB2CHRNA4CARM1
SCHEMBL15790968 0.89 CARM1 (0.64) TSHRALDH1A1CHRNB2CHRNA4CARM1
Hydrochloric Acid SCHEMBL27850742 0.88 SIGMAR1 (0.53) TSHRALDH1A1CHRNB2CHRNA4CARM1
Dibemethine SCHEMBL276863 0.87 ALDH1A1 (0.70) TSHRALDH1A1CARM1PRMT6PRMT8
SCHEMBL12763726 0.87 CHRNB2 (0.56) ALDH1A1CHRNB2CHRNA4CARM1PRMT6
Dibemethine SCHEMBL10542007 0.87 ALDH1A1 (0.70) TSHRALDH1A1CARM1PRMT6PRMT8
SCHEMBL22134260 0.86 ALDH1A1 (0.77) TSHRALDH1A1CHRNB2CHRNA4CARM1
SCHEMBL15790823 0.85 SIGMAR1 (0.65) TSHRALDH1A1CARM1PRMT6PRMT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 914 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119735814-A Preparation method of side hydrogen polysiloxane modified phenolic epoxy resin and coating 南京理工大学 2025-04-01 CN claimed
CN-119661472-A Para-hydroxystyrene derivative containing tertiary amine structure and preparation method thereof 江苏集萃光敏电子材料研究所有限公司 2025-03-21 CN claimed
WO-2025005755-A1 COMPOSITION FOR MANUFACTURING ANISOTROPIC CONDUCTIVE FILM 엔젯 주식회사 2025-01-02 WO claimed
CN-116811375-B Self-repairing fiber reinforced laminate and preparation method thereof 湖北三峡实验室 2024-07-05 CN claimed
CN-116811375-A Self-repairing fiber reinforced laminate and preparation method thereof 湖北三峡实验室 2023-09-29 CN claimed
CN-116554437-A Linear fluorine-containing glycidyl ether and preparation method and application thereof 哈尔滨工业大学 2023-08-08 CN claimed
CN-111899954-B Thermosetting epoxy resin composition for packaging inductor and preparation method thereof 江苏中科科化新材料股份有限公司 2023-03-24 CN claimed
CN-107955335-B Preparation method of epoxy resin composition prepared by using stirrer 江苏科化新材料科技有限公司 2021-05-28 CN claimed
CN-112724603-A High-reliability epoxy plastic package material for semiconductor packaging 江苏科化新材料科技有限公司 2021-04-30 CN claimed
US-10865217-B2 Process for the preparation of 5-(4-cyanophenoxy)-1,3-dihydro-1-hydroxy-[2,1]-benzoxaborole and polymorphs thereof MSN LABORATORIES PRIVATE LIMITED, R & D CENTER (IN) 2020-12-15 US claimed
US-6583295-B1 Amine salts of such as lovastatin, pravastatin, simvastatin, mevastatin or atorvastatin LEK PHARMACEUTICALS D.D. (SI) 2003-06-24 US claimed
WO-2003009847-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEM, INC. (US) 2003-02-06 WO claimed
WO-2003009850-A1 SUBSTITUTED PIPERAZINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEN INC. (US) 2003-02-06 WO claimed
US-6414069-B1 MULTILAYER; ION EXCHANGING BOARD OF TRUSTEES OF MICHIGAN UNIVERSITY 2002-07-02 US claimed
CN-1318046-A New salts of HMG-CoA reductase inhibitors LED PHARMACEUTICAL AND CHEMICA (SI) 2001-10-17 CN claimed
WO-2001066626-A1 HYBRID MIXED ION CLAY STRUCTURES FOR POLYMER NANOCOMPOSITE FORMATION MICHIGAN STATE UNIVERSITY (US) 2001-09-13 WO claimed
EP-0145323-B1 TOUGHENED EPOXY COMPOSITION LOCTITE CORPORATION (US) 1988-05-11 EP claimed
EP-0063359-B1 1,4-DIHYDROPYRIDINE DERIVATIVES AND PROCESSES FOR PREPARING THE SAME BANYU PHARMACEUTICAL CO., LTD. (JP) 1985-12-11 EP claimed
EP-0145323-A2 Toughened epoxy composition LOCTITE CORPORATION (US) 1985-06-19 EP claimed
US-4410730-A Process for the production of o-(N-monosubstituted amino)benzyl alcohols SHIONOGI & CO., LTD. (JP) 1983-10-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10865217-B2 Process for the preparation of 5-(4-cyanophenoxy)-1,3-dihydro-1-hydroxy-[2,1]-benzoxaborole and polymorphs thereof CYP1B1, CYP4B1, CYP1A1 TSHR 4763/4885ALDH1A1 114/4885CHRNB2 1411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.